Cytokeratin 6

QR028, Rb

Technische Daten
Status:In Vitro Diagnostic Use (IVD)
Ig Unterklasse:IgG
Immunogen:Synthetic peptide of human CK6
Vorbehandlung:ProTaqs® Antigen Enhancer I (Cat. No. 401602092) or ProTaqs® Antigen Enhancer IV (Cat. No. 401602392)
Zelluläre Lokalisation:Cytoplasmic, membranous
Kontrolle:Skin, squamous cell carcinoma
Change(s) made:Complete revision
Synonyme:KRT6A, CK6A, CK6B, CK6C, CK6D, CK 6E, K6A, K6C, K6D, KRT6C, Cytokeratin 6a, Cytokeratin 6B, Cytokeratin 6C, Cytokeratin 6D, Cytokeratin 6E, Cytokeratin6, k6a keratin, K6B, K6b keratin, K6c keratin, K6d keratin, K6e keratin, k6hf, Keratin 6 isoform K6e, Keratin 6C, Keratin 6E, Keratin K6h, Keratin type II cytoskeletal 6A, Keratin type II cytoskeletal 6B, Keratin type II cytoskeletal 6C, Keratin type II cytoskeletal 6D, Keratin type II cytoskeletal 6E, KRT6, KRT6A, KRT6B, KRT6C, KRT6D, KRT6E, MGC102925.
Verfügbar in folgenden Ländern:worldwide

Keratins are cytoplasmic intermediate filament proteins expressed by epithelial cells. CK6 is a type II keratin constitutively expressed in distinct types of epithelia such as those in oral mucosa, esophagus, papillae of tongue and hair follicle outer root sheath.